Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS/MS analysis. 2007

Ming Yao, and Mingshe Zhu, and Michael W Sinz, and Hongjian Zhang, and W Griffith Humphreys, and A David Rodrigues, and Renke Dai
Department of Biotransformation, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, NJ 08543, USA. ming.yao@bms.com

Substrate inhibition assays for five of the major CYP enzymes (phenacetin for CYP1A2, diclofenac for CYP2C9, (S)-mephenytoin for CYP2C19, dextromethorphan for CYP2D6 and midazolam and testosterone for CYP3A4) in human liver microsomes were developed. Fully automated incubations were conducted in a 96-well format under optimized enzyme kinetic conditions. Metabolites of probe substrates were analyzed with rapid LC-MS/MS methods. The assays were fully validated following the procedure for validating bioanalytical methods recommended by regulatory agencies. Quality control samples and a positive control CYP inhibitor were included in each assay. The IC(50) values determined for typical CYP inhibitors were reproducible and consistent with those reported in the literature. The high quality and throughput of these assays make them ideally suited for providing information for decision making in late drug discovery and early development and for providing labeling input for new drug registrations.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006899 Mixed Function Oxygenases Widely distributed enzymes that carry out oxidation-reduction reactions in which one atom of the oxygen molecule is incorporated into the organic substrate; the other oxygen atom is reduced and combined with hydrogen ions to form water. They are also known as monooxygenases or hydroxylases. These reactions require two substrates as reductants for each of the two oxygen atoms. There are different classes of monooxygenases depending on the type of hydrogen-providing cosubstrate (COENZYMES) required in the mixed-function oxidation. Hydroxylase,Hydroxylases,Mixed Function Oxidase,Mixed Function Oxygenase,Monooxygenase,Monooxygenases,Mixed Function Oxidases,Function Oxidase, Mixed,Function Oxygenase, Mixed,Oxidase, Mixed Function,Oxidases, Mixed Function,Oxygenase, Mixed Function,Oxygenases, Mixed Function
D001189 Aryl Hydrocarbon Hydroxylases A large group of cytochrome P-450 (heme-thiolate) monooxygenases that complex with NAD(P)H-FLAVIN OXIDOREDUCTASE in numerous mixed-function oxidations of aromatic compounds. They catalyze hydroxylation of a broad spectrum of substrates and are important in the metabolism of steroids, drugs, and toxins such as PHENOBARBITAL, carcinogens, and insecticides. Microsomal Monooxygenases,Xenobiotic Monooxygenases,Hydroxylases, Aryl Hydrocarbon,Monooxygenases, Microsomal,Monooxygenases, Xenobiotic
D001322 Autoanalysis Method of analyzing chemicals using automation. Autoanalyses

Related Publications

Ming Yao, and Mingshe Zhu, and Michael W Sinz, and Hongjian Zhang, and W Griffith Humphreys, and A David Rodrigues, and Renke Dai
August 2010, Drug metabolism letters,
Ming Yao, and Mingshe Zhu, and Michael W Sinz, and Hongjian Zhang, and W Griffith Humphreys, and A David Rodrigues, and Renke Dai
January 2013, Drug metabolism and drug interactions,
Ming Yao, and Mingshe Zhu, and Michael W Sinz, and Hongjian Zhang, and W Griffith Humphreys, and A David Rodrigues, and Renke Dai
April 2007, International journal of pharmaceutics,
Ming Yao, and Mingshe Zhu, and Michael W Sinz, and Hongjian Zhang, and W Griffith Humphreys, and A David Rodrigues, and Renke Dai
July 2018, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
Ming Yao, and Mingshe Zhu, and Michael W Sinz, and Hongjian Zhang, and W Griffith Humphreys, and A David Rodrigues, and Renke Dai
February 2009, Phytotherapy research : PTR,
Ming Yao, and Mingshe Zhu, and Michael W Sinz, and Hongjian Zhang, and W Griffith Humphreys, and A David Rodrigues, and Renke Dai
September 2008, Journal of pharmaceutical and biomedical analysis,
Ming Yao, and Mingshe Zhu, and Michael W Sinz, and Hongjian Zhang, and W Griffith Humphreys, and A David Rodrigues, and Renke Dai
March 2015, Biomedical chromatography : BMC,
Ming Yao, and Mingshe Zhu, and Michael W Sinz, and Hongjian Zhang, and W Griffith Humphreys, and A David Rodrigues, and Renke Dai
January 1999, Xenobiotica; the fate of foreign compounds in biological systems,
Ming Yao, and Mingshe Zhu, and Michael W Sinz, and Hongjian Zhang, and W Griffith Humphreys, and A David Rodrigues, and Renke Dai
July 2016, Toxicological research,
Ming Yao, and Mingshe Zhu, and Michael W Sinz, and Hongjian Zhang, and W Griffith Humphreys, and A David Rodrigues, and Renke Dai
August 2014, Toxicology letters,
Copied contents to your clipboard!